Proto Labs (NYSE:PRLB) Director Buys $49,089.60 in Stock

Proto Labs, Inc. (NYSE:PRLB) Director Rainer Gawlick bought 720 shares of the firm’s stock in a transaction that occurred on Tuesday, November 3rd. The shares were acquired at an average price of $68.18 per share, with a total value of $49,089.60. Following the completion of the transaction, the director directly owned 46,813 shares of the company’s stock, valued at $3,191,710.34. This trade represents a 1.56% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Proto Labs Stock Performance

Shares of PRLB stock opened at $65.97 on Friday. The stock’s 50-day moving average is $85.06 and its two-hundred day moving average is $73.39. Proto Labs, Inc. has a 1 year low of $46.07 and a 1 year high of $99.96. The firm has a market cap of $1.57 billion, a price-to-earnings ratio of 46.13 and a beta of 1.52.

Proto Labs (NYSE:PRLB) last posted its quarterly earnings results on Thursday, October 29th. The industrial products company reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.60 by $0.03. Proto Labs had a return on equity of 5.40% and a net margin of 6.04%. The firm had revenue of $154.32 million during the quarter, compared to the consensus estimate of $149.31 million. During the same quarter in the previous year, the business earned $0.47 earnings per share. The firm’s quarterly revenue was up 13.7% compared to the same quarter last year. As a group, research analysts predict that Proto Labs, Inc. will post 1.52 EPS for the current year.

Wall Street Analysts Forecast Growth

PRLB has been the topic of a number of research analyst reports. Weiss Ratings cut shares of Proto Labs from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday. Needham & Company LLC upped their price objective on Proto Labs from $87.00 to $110.00 and gave the company a “buy” rating in a research report on Friday, October 23rd. Wall Street Zen lowered shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 18th. Zacks Research cut shares of Proto Labs from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 2nd. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of Proto Labs in a report on Tuesday, October 27th. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Proto Labs has a consensus rating of “Moderate Buy” and an average target price of $100.50.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC grew its stake in Proto Labs by 9.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,337 shares of the industrial products company’s stock worth $127,000 after buying an additional 118 shares in the last quarter. Illinois Municipal Retirement Fund increased its holdings in shares of Proto Labs by 2.4% in the 1st quarter. Illinois Municipal Retirement Fund now owns 12,871 shares of the industrial products company’s stock valued at $734,000 after acquiring an additional 300 shares during the last quarter. Signaturefd LLC lifted its stake in shares of Proto Labs by 240.0% during the 3rd quarter. Signaturefd LLC now owns 527 shares of the industrial products company’s stock worth $50,000 after purchasing an additional 372 shares during the period. Balance Wealth Partners LLC bought a new position in Proto Labs during the 3rd quarter worth approximately $36,000. Finally, Farther Finance Advisors LLC lifted its stake in Proto Labs by 24.3% during the third quarter. Farther Finance Advisors LLC now owns 2,012 shares of the industrial products company’s stock valued at $191,000 after buying an additional 393 shares in the last quarter. 84.54% of the stock is owned by institutional investors and hedge funds.

About Proto Labs

Proto Labs, Inc (NYSE: PRLB), operating as Protolabs, is a digital manufacturing company that provides rapid prototyping and on-demand production services. The company uses automated quoting and manufacturing systems to help engineers and product developers produce custom parts without relying on traditional, lengthy tooling and procurement processes.

Protolabs offers computer numerical control (CNC) machining, injection molding, 3D printing and sheet-metal fabrication. Its services support the development and production of components in a range of materials and are used across industries including automotive, aerospace, medical, electronics and consumer products.

Founded in 1999 by entrepreneur Larry Lukis, the company has expanded its reach beyond its original U.S.